Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant ...
TG4050: Promising Phase I data to be presented at SITC 2024 providing clinical proof of principle in adjuvant head and neck cancer ...
Steering America away from far-right illiberalism means scrutinizing the Big Tech powerbrokers who control our social media ...
Creative Bloq on MSN19h
Audi scraps its logo in bold new EV brandSo it's somewhat surprising that the brand is ditching the rings for a new EV brand.After months of rumous, Audi has unveiled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback